Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07335913 · ClinicalTrials.gov registry record · Phase 1

Phase 1 Study of SBS-147 in Healthy Adults

A Phase 1 study of Pain and Pain, Acute, sponsored by Sparian Biosciences.

Recruiting
Registry status
Phase 1
Development phase
80
Enrollment target
1
Study location

NCT07335913 is a Phase 1 study of Pain and Pain, Acute that is actively recruiting participants, run by Sparian Biosciences. The registered enrollment target is 80 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07335913, a Phase 1 study of Pain and Pain, Acute, is actively recruiting participants, sponsored by Sparian Biosciences.

RECRUITING
Registry status
Phase 1
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

This study is part of the HEAL Initiative supported by the NIH. The purpose of this study is to learn how safe the study drug, SBS-147, is and how people's bodies respond to and process it. Researchers will also look for any side effects that may occur when taking SBS-147. Some participants will receive SBS-147, and others will receive a placebo, which looks the same but does not contain any medicine. This helps researchers fairly compare results. The study includes two parts: Single-Dose Group, where Participants receive SBS-147 or placebo one time. Multiple-Dose Group, where Participants receive SBS-147 or placebo once or twice daily for 7 days.

Conditions Studied

Interventions

  • DRUG Placebo
  • DRUG SBS-147

Study Locations (1)

California

  • AltaSciences, Inc - Cypress

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2026-01-08
Est. Completion 2027-02-28
Phase Phase 1

Sponsor

Sparian Biosciences

2 total trials

What the Registry Record Tells You About NCT07335913

The ClinicalTrials.gov registry entry for NCT07335913 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (74% lower). The listed sponsor is Sparian Biosciences, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT07335913 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT07335913 about?

NCT07335913 is a clinical study titled "Phase 1 Study of SBS-147 in Healthy Adults". This study is part of the HEAL Initiative supported by the NIH. The purpose of this study is to learn how safe the study drug, SBS-147, is and how people's bodies respond to and process it. Researchers will also look for any side effects that may occur when taking SBS-147. Some participants will r...

What is the current status of trial NCT07335913?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 80 participants. The study started on 2026-01-08. Estimated completion is 2027-02-28.

What conditions does trial NCT07335913 study?

This clinical trial studies the following conditions: Pain, Pain, Acute.

What interventions are being tested in trial NCT07335913?

The interventions under investigation include: Placebo (DRUG), SBS-147 (DRUG).

Who is sponsoring clinical trial NCT07335913?

This trial is sponsored by Sparian Biosciences, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07335913 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.